Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 193 clinical trials
Treatment of Pregnant Women With OUD

The investigators are testing two models of support for pregnant women with an opioid use disorder (OUD)

  • 0 views
  • 19 Feb, 2024
  • 12 locations
Comprehensive Care Community and Culture Study

This randomized trial is evaluating whether socioeconomically disadvantaged Medicare patients at increased risk of hospitalization experience fewer hospitalization if those patients are offered care in: 1) ACCT, where patients receive care from different physicians in the hospital and the clinic settings and have access to nurse and social worker care …

  • 0 views
  • 19 Feb, 2024
  • 1 location
Codman Catheter/Synchromed Pump Hepatic Artery Chemotherapy for Unresectable Colorectal Metastases/Intrahepatic Cholangiocarcinoma

This study aims to test the safety of hepatic artery infusion pump placement, a standard surgical procedure, and intraarterial chemotherapy initiation with the standard medication floxuridine (FUDR), using the Medtronic Synchromed II pump combined with the Codman arterial catheter in patients with unresectable (not removable by surgery) liver metastases from …

antiretroviral therapy
immunodeficiency
adenocarcinoma
metastasis
liver metastasis
  • 0 views
  • 19 Feb, 2024
  • 1 location
Pemigatinib in Treating Patients With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Including FGFR2 Rearrangement

This is a phase 2 study to investigate the efficacy and safety of Pemigatinib in treating patients with advanced/metastatic or surgically unresectable cholangiocarcinoma with FGFR2 rearrangement who have failed at least 1 previous therapy

pemigatinib
FGFR2
measurable disease
non-resectable cholangiocellular carcinoma
non-resectable cholangiocarcinoma
  • 0 views
  • 19 Feb, 2024
  • 1 location
Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of CC-94676 in Subjects With Metastatic Castration-Resistant Prostate Cancer

This is a first in human study to assess the safety, tolerability, PK, PD and preliminary efficacy of CC-94676 in men with progressive metastatic castration-resistant prostate cancer.

adenocarcinoma
metastatic hormone refractory prostate cancer
metastatic castration-resistant prostate cancer
androgens
testosterone
  • 0 views
  • 19 Feb, 2024
  • 6 locations
A Study of CC-98633 BCMA-targeted Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed and/or Refractory Multiple Myeloma

The dose-escalation part (Part A) of the study is to evaluate the safety and tolerability of increasing dose levels of CC-98633 to establish a recommended Phase 2 dose (RP2D); and the dose-expansion part (Part B) of the study is to further evaluate the safety, pharmacokinetics/pharmacodynamics, and efficacy of CC-98633 at …

ixazomib
immunotherapeutic agent
refractory multiple myeloma
lenalidomide
bortezomib
  • 0 views
  • 19 Feb, 2024
  • 9 locations
Adaptative MR-Guided Stereotactic Body Radiotherapy of Liver Tumors

Stereotactic radiotherapy is a recent technique proposed to hepatic metastases treatment from solid cancers and primary hepatic lesions (HCC or cholangiocarcinomas); it is possible to deliver high doses of radiation in the most conformational way possible in order to limit the irradiation of the non-tumor liver.

skin cancer
liver cancer
cancer
stereotactic radiation therapy
colorectal cancer
  • 0 views
  • 19 Feb, 2024
  • 1 location
Prospective Register on the Etiologies of Cardiogenic Shock and Their Prognosis at One Year.

This definition of the European Society of Cardiology (ESC) masks however the great variability of hemodynamic tables grouped under the term of CC and severity levels, also variable.However, it was suggested that the etiology of CC influenced both its hemodynamic profile and therefore its therapeutic management but also its prognosis …

vasopressor
hypoperfusion
hyperlactatemia
oliguria
heart failure
  • 0 views
  • 19 Feb, 2024
  • 1 location
Saliva as Source of Detection for SARS-CoV-2

Eligibility NIH staff members age 18 and older who are taking part in NIH CC SARS-CoV-2 surveillance. Design The Occupational Medical Service (OMS) collects NP swabs as part of standard NIH staff screening.

nasal swab
SARS
acute respiratory syndrome (sars)
nasopharyngeal swab
discomfort
  • 0 views
  • 19 Feb, 2024
  • 1 location
Surveillance of Individuals Following SARS-CoV-2 Exposure

Background People who have had contact with a person with a known SARS-CoV-2 infection are being told to self-quarantine for 14 days. This is done to avoid potential virus spread. But the actual time it takes for a person to develop an infection after being exposed to the virus is …

acute respiratory syndrome (sars)
SARS
covid-19
  • 0 views
  • 19 Feb, 2024
  • 1 location